Article

Femtosecond laser-enabled keratoplasty 'exciting' news for corneal transplantation

Femtosecond laser-enabled keratoplasty is thought to be the biggest advance in corneal transplantation in the past 20 years, according to Yaron S. Rabinowitz, MD, chief of ophthalmology, Cedars-Sinai Medical Center, Los Angeles, United States.

Femtosecond laser-enabled keratoplasty is thought to be the biggest advance in corneal transplantation in the past 20 years, according to Yaron S. Rabinowitz, MD, chief of ophthalmology, Cedars-Sinai Medical Center, Los Angeles, United States.

"We know penetrating keratoplasty works extremely well, but there are many factors contributing to astigmatism," he said.

Femtosecond laser-enabled keratoplasty enables ophthalmologists to perform multiple cuts the entire length of the endothelium using one of three incision patterns: top hat, mushroom, or zig zag.

"You actually can get much better apposition of the wound," Dr. Rabinowitz said. "You also get much better wound healing . . . . And the advantage is, you get significant reduction of astigmatism very early on."

Data from almost every one of six studies from six different countries (Por, Singapore; Daya, United Kingdom; Burrato, Italy; Naranjo-Tackman, Mexico; Steinert, United States; and Nuijts, The Netherlands) presented at the 2007 annual meeting of the American Society of Cataract and Refractive Surgery demonstrate "significant reduction in the postoperative cylinder" with femtosecond laser-enabled keratoplasty, he said, adding that the range with conventional penetrating keratoplasty is about 4 to 25 D.

The range seen with femtosecond laser-enabled keratoplasty is "extremely narrow," Dr. Rabnowitz said. "It's very exciting news in the management not only of keratoconus but also post-LASIK ectasia."

He spoke of the surgery using a particular femtosecond laser (IntraLase FS, Advanced Medical Optics).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.